From: Intracellular molecular effects of insulin resistance in patients with metabolic syndrome
 | MetS (n = 40) | Controls (n = 20) | P |
---|---|---|---|
Sex (M/F) | 32/8 | 14/6 | NS |
Age (years) | 60 ± 3 | 58 ± 2 | NS |
BMI (Kg/m2) | 30.1 ± 1.2 | 23.6 ± 0.8 | P < 0.01 |
Blood pressure (mm Hg) | 152/89 ± 2/1 | 129/79 ± 3/2 | P < 0.01 |
Waist circumference | 108 ± 5 | 82 ± 4 | P < 0.01 |
Fasting glucose (mg/dl) | 116 ± 7 | 87 ± 3 | P < 0.01 |
OGTT (serum glucose after 120 min) (mg/dl) | 187 ± 8 | 98 ± 4 | P < 0.01 |
Serum cholesterol (mg/dl) | 244 ± 5 | 186 ± 3 | P < 0.01 |
Serum triglycerides (mg/dl) | 207 ± 33 | 85 ± 20 | P < 0.01 |
LDL cholesterol (mg/dl) | 112 ± 7 | 100 ± 6 | NS |
HDL cholesterol (mg/dl) | 47 ± 5 | 50 ± 3 | NS |
Serum creatinine | 1.1 ± 0.1 | 0.9 ± 0.1 | NS |
Fasting insulin (μIU/mL) | 12.0 ± 0.9 | 3.71 ± 0.4 | P < 0.001 |
HOMA index | 3.45 ± 2 | 0.8 ± 0.6 | P < 0.01 |